Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACB Aurora Cannabis	$4.54 +1.5%	$5.03	$3.42 ▼ $7.20	$254.35M	1.75	1.57 million shs	228,951 shs
CGC Canopy Growth	$1.26 +5.5%	$1.43	$0.77 ▼ $8.65	$230.76M	0.73	6.28 million shs	1.25 million shs
GWPH GW Pharmaceuticals	$218.96	$218.59	$87.07 ▼ $219.57	$6.86B	2.15	899,771 shs	N/A
HEXO HEXO	$0.71 +2.5%	$0.87	$0.66 ▼ $3.84	$31.24M	1.35	880,508 shs	305,500 shs
TLRY Tilray Brands	$0.48 -1.9%	$0.43	$0.35 ▼ $2.15	$481.11M	1.82	29.73 million shs	9.86 million shs

2025 Gold Forecast: A Perfect Storm for Demand

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACB Aurora Cannabis	+3.95%	+14.03%	-14.20%	+4.20%	-1.11%
CGC Canopy Growth	+5.31%	-3.25%	-1.65%	+25.62%	-80.99%
GWPH GW Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
HEXO HEXO	0.00%	0.00%	0.00%	0.00%	0.00%
TLRY Tilray Brands	+15.09%	+23.21%	+19.18%	-21.48%	-70.59%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACB Aurora Cannabis	0.2918 of 5 stars	0.0	1.0	0.0	0.0	2.3	0.8	0.6
CGC Canopy Growth	2.6371 of 5 stars	2.5	3.0	0.0	0.0	2.2	0.0	1.3
GWPH GW Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HEXO HEXO	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLRY Tilray Brands	1.7417 of 5 stars	3.1	1.0	0.0	0.0	2.5	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACB Aurora Cannabis	3.67	Strong Buy	N/A	N/A
CGC Canopy Growth	1.00	Sell	$2.00	59.36% Upside
GWPH GW Pharmaceuticals	0.00	N/A	N/A	N/A
HEXO HEXO	0.00	N/A	N/A	N/A
TLRY Tilray Brands	2.25	Hold	$1.92	302.66% Upside

Current Analyst Ratings Breakdown

Latest ACB, CGC, HEXO, GWPH, and TLRY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/30/2025	CGC Canopy Growth	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underweight ➝ Underweight
4/14/2025	TLRY Tilray Brands	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
4/9/2025	TLRY Tilray Brands	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$2.00 ➝ $1.00

(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACB Aurora Cannabis	$246.72M	1.03	$0.65 per share	7.03	$7.78 per share	0.58
CGC Canopy Growth	$225.65M	1.02	N/A	N/A	$1.90 per share	0.66
GWPH GW Pharmaceuticals	$311.33M	22.05	$0.01 per share	18,588.22	$23.48 per share	9.33
HEXO HEXO	$146.20M	0.21	N/A	N/A	$2.44 per share	0.29
TLRY Tilray Brands	$788.94M	0.61	N/A	N/A	$4.14 per share	0.11

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACB Aurora Cannabis	$1.63M	$0.11	41.14	10.31	N/A	1.32%	0.13%	0.10%	8/6/2025 (Estimated)
CGC Canopy Growth	-$429.86M	-$4.04	N/A	N/A	N/A	-195.76%	-88.54%	-40.78%	8/8/2025 (Estimated)
GWPH GW Pharmaceuticals	-$9.02M	-$0.24	N/A	608.22	N/A	-11.05%	-7.46%	-6.13%	N/A
HEXO HEXO	-$845.90M	-$5.21	N/A	N/A	N/A	-235.33%	-74.04%	-32.51%	N/A
TLRY Tilray Brands	-$244.98M	-$1.05	N/A	N/A	N/A	-113.85%	-7.40%	-6.02%	8/4/2025 (Estimated)

Latest ACB, CGC, HEXO, GWPH, and TLRY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
6/18/2025	Q4 2025	ACB Aurora Cannabis	$0.11	$0.07	-$0.04	-$0.24	$88.85 million	$63.34 million
5/30/2025	Q4 2025	CGC Canopy Growth	-$0.28	-$0.94	-$0.66	-$1.00	$71.84 million	$45.30 million
4/8/2025	Q3 2025	TLRY Tilray Brands	-$0.04	-$0.10	-$0.06	-$0.87	$213.38 million	$185.78 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACB Aurora Cannabis	N/A	N/A	N/A	N/A	N/A
CGC Canopy Growth	N/A	N/A	N/A	N/A	N/A
GWPH GW Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
HEXO HEXO	N/A	N/A	N/A	N/A	N/A
TLRY Tilray Brands	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACB Aurora Cannabis	0.13	4.31	2.16
CGC Canopy Growth	0.62	3.12	2.10
GWPH GW Pharmaceuticals	0.01	5.13	4.31
HEXO HEXO	0.01	0.41	0.24
TLRY Tilray Brands	0.12	2.62	1.61

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACB Aurora Cannabis	47.63%
CGC Canopy Growth	3.33%
GWPH GW Pharmaceuticals	81.00%
HEXO HEXO	7.78%
TLRY Tilray Brands	9.35%

Insider Ownership

Company	Insider Ownership
ACB Aurora Cannabis	0.01%
CGC Canopy Growth	1.30%
GWPH GW Pharmaceuticals	3.10%
HEXO HEXO	4.69%
TLRY Tilray Brands	0.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACB Aurora Cannabis	1,130	56.21 million	56.21 million	Optionable
CGC Canopy Growth	3,150	183.87 million	181.48 million	Optionable
GWPH GW Pharmaceuticals	1,161	31.35 million	N/A	Optionable
HEXO HEXO	1,277	44.00 million	41.93 million	Optionable
TLRY Tilray Brands	2,650	1.01 billion	1.00 billion	Optionable

ACB, CGC, HEXO, GWPH, and TLRY Headlines

Recent News About These Companies

Tilray Brands (NASDAQ:TLRY) Trading 4.1% Higher - Here's Why

July 2 at 1:37 PM | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Stock Price Down 1.3% - Should You Sell?

July 1 at 3:40 PM | marketbeat.com

Beers, Live Music, Hot Dogs and Fireworks: Everything You Need for an Epic 4th Of July Celebration

July 1 at 8:19 AM | financialpost.comF

Breckenridge Distillery Unveils Limited-Edition Collectors Art Series Collaboration with Renowned Artist Miles Toland

July 1 at 7:04 AM | financialpost.comF

Breckenridge Distillery Unveils Limited-Edition Collectors Art Series Collaboration with Renowned Artist Miles Toland

July 1 at 7:00 AM | globenewswire.com

TLRY - Tilray Brands Inc News - Morningstar

June 28, 2025 | morningstar.comM

Tilray Brands, Inc. (TLRY) Stock Declines While Market Improves: Some Information for Investors

June 27, 2025 | zacks.com

Tilray Brands (NASDAQ:TLRY) Shares Up 3.9% - Should You Buy?

June 26, 2025 | marketbeat.com

Tilray Brands (NasdaqGS:TLRY) Advances Medical Cannabis Research With New Bioavailability Study

June 26, 2025 | finance.yahoo.com

Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

June 26, 2025 | finance.yahoo.com

Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation

June 26, 2025 | globenewswire.com

TLRY Stock - Tilray Brands Inc Stock Price Quote - XTSE - Morningstar

June 26, 2025 | morningstar.comM

Here Is A List Of 3 Canadian Marijuana Stocks To Watch 2025

June 25, 2025 | marijuanastocks.comM

Tilray Medical Launches “Good Supply” Cannabis Brand in Germany

June 25, 2025 | insidermonkey.com

Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use

June 24, 2025 | finance.yahoo.com

Tilray sets medical cannabis milestone in Italy

June 24, 2025 | msn.com

Tilray Brands Stock Price, Quotes and Forecasts | NASDAQ:TLRY - Benzinga

June 24, 2025 | benzinga.com

Tilray Brands (NASDAQ:TLRY) Trading 4% Higher - Should You Buy?

June 24, 2025 | marketbeat.com

Tilray Medical Receives Italy's First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use

June 24, 2025 | globenewswire.com

Tilray Brands, Inc. Unveils Exciting 2025 Summer Cannabis Collection Featuring Innovative Formats and Flavors

June 23, 2025 | quiverquant.comQ

Elevate Your Summer with Canada’s Leading Cannabis Brands and Products by Tilray Brands

June 23, 2025 | financialpost.comF

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB, CGC, HEXO, GWPH, and TLRY Company Descriptions

Aurora Cannabis NASDAQ:ACB

$4.54 +0.07 (+1.45%)

As of 10:33 AM Eastern

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Canopy Growth NASDAQ:CGC

$1.25 +0.07 (+5.46%)

As of 10:33 AM Eastern

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

GW Pharmaceuticals NASDAQ:GWPH

GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.

HEXO NYSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

Tilray Brands NASDAQ:TLRY

$0.48 -0.01 (-1.90%)

As of 10:34 AM Eastern

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time